G., Vernacotola, S., Peruzzi, L., Tabolacci, E., Mila, M., Militerni, R., Musumeci, S., Ramos, F
In fact, platelets of T2D patients have decreased sensitivity to insulin, which may lead to increased platelet reactivity and a higher risk of atherothrombotic events among insulin-treated subjects ( Spectre et al
First, their interaction with semaglutide peptide stability has not been studied in controlled conditions
The implication is editorial coverage of Willow specifically, but we couldnt surface any of the cited articles through a direct search
In a sensitivity analysis stratified by diabetes status, GLP-1 use was associated with lower fracture risk among those with T2D (HR, 0.91 [95% CI, 0.88-0.95]) but with increased fracture risk among those without T2D (HR, 1.13 [95% CI, 1.04-1.23]